Martin Duerden

913 total citations
32 papers, 518 citations indexed

About

Martin Duerden is a scholar working on Economics and Econometrics, Geriatrics and Gerontology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Martin Duerden has authored 32 papers receiving a total of 518 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Economics and Econometrics, 10 papers in Geriatrics and Gerontology and 7 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Martin Duerden's work include Pharmaceutical Practices and Patient Outcomes (10 papers), Health Systems, Economic Evaluations, Quality of Life (9 papers) and Pharmaceutical Economics and Policy (8 papers). Martin Duerden is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (10 papers), Health Systems, Economic Evaluations, Quality of Life (9 papers) and Pharmaceutical Economics and Policy (8 papers). Martin Duerden collaborates with scholars based in United Kingdom, Germany and South Africa. Martin Duerden's co-authors include Dyfrig Hughes, Rupert Payne, Polly Duncan, David Price, Stewart W Mercer, Carol Sinnott, Colin Bradley, Molly Byrne, Norma O’Flynn and Nadeem Qureshi and has published in prestigious journals such as British Journal of Clinical Pharmacology, Implementation Science and PharmacoEconomics.

In The Last Decade

Martin Duerden

29 papers receiving 495 citations

Peers

Martin Duerden

GHP

PPCH

PRM

Petra Kaufmann‐Kolle Germany

Qais Alefan Jordan

Adekunle Olatayo Adeoti Nigeria

Tamrat Befekadu Abebe Ethiopia

Asnakew Achaw Ayele Ethiopia

Judith Mackson Australia

Virginia Hernandez Santiago United Kingdom

Rachael Posey United States

Surrey M. Walton United States

Yonas Getaye Tefera Ethiopia

Petra Kaufmann‐Kolle Germany

Martin Duerden

203 ×1.0

181 ×1.3

241 ×2.3

GHP

112 ×1.3

PPCH

45 ×0.6

PRM

Citations per year, relative to Martin Duerden Martin Duerden (= 1×) peers Petra Kaufmann‐Kolle

Countries citing papers authored by Martin Duerden

Since Specialization

Citations

This map shows the geographic impact of Martin Duerden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Duerden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Duerden more than expected).

Fields of papers citing papers by Martin Duerden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Duerden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Duerden. The network helps show where Martin Duerden may publish in the future.

Co-authorship network of co-authors of Martin Duerden

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Duerden. A scholar is included among the top collaborators of Martin Duerden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Duerden. Martin Duerden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Abdullah, Baharudin, et al.. (2024). Treatment of Acute Sore Throat in Malaysia: A Consensus of Multidisciplinary Recommendations Using Modified Delphi Methodology. Infection and Drug Resistance. Volume 17. 4149–4160.

Löffler, Christin, Attila Altiner, An De Sutter, et al.. (2022). Challenges and opportunities for general practice specific CME in Europe – a narrative review of seven countries. BMC Medical Education. 22(1). 761–761. 10 indexed citations

Essack, Sabiha Y., John Bell, Martin Duerden, et al.. (2020). Point-of-Care Testing for Pharyngitis in the Pharmacy. Antibiotics. 9(11). 743–743. 15 indexed citations

Duerden, Martin, et al.. (2020). Major global discrepancies in guidelines for sore throat (acute pharyngitis). 3273–3273.

Essack, Sabiha Y., et al.. (2019). Topical (local) antibiotics for respiratory infections with sore throat: An antibiotic stewardship perspective. Journal of Clinical Pharmacy and Therapeutics. 44(6). 829–837. 18 indexed citations

Duncan, Polly, Martin Duerden, & Rupert Payne. (2016). Deprescribing: a primary care perspective. European Journal of Hospital Pharmacy. 24(1). 37–42. 69 indexed citations

Sinnott, Carol, Stewart W Mercer, Rupert Payne, et al.. (2015). Improving medication management in multimorbidity: development of the MultimorbiditY COllaborative Medication Review And DEcision Making (MY COMRADE) intervention using the Behaviour Change Wheel. Implementation Science. 10(1). 132–132. 87 indexed citations

Duerden, Martin, Norma O’Flynn, & Nadeem Qureshi. (2015). Cardiovascular risk assessment and lipid modification: NICE guideline. British Journal of General Practice. 65(636). 378–380. 39 indexed citations

Duerden, Martin & Rupert Payne. (2015). Medicines management: the importance of when to stop. Prescriber. 26(8). 24–26. 2 indexed citations

10.

Payne, Rupert & Martin Duerden. (2015). Polypharmacy – appropriate, problematic or both?. Prescriber. 26(4). 31–34. 4 indexed citations

11.

Velden, Alike W. van der, Martin Duerden, John Bell, et al.. (2013). Prescriber and Patient Responsibilities in Treatment of Acute Respiratory Tract Infections — Essential for Conservation of Antibiotics. Antibiotics. 2(2). 316–327. 34 indexed citations

12.

Fleetcroft, Robert, Peter Schofield, Martin Duerden, & Mark Ashworth. (2012). Achievement of cholesterol targets and prescribing of higher-cost statins: a cross-sectional study in general practice. British Journal of General Practice. 62(605). e815–e820. 3 indexed citations

13.

Duerden, Martin & Dyfrig Hughes. (2010). Generic and therapeutic substitutions in the UK: are they a good thing?. British Journal of Clinical Pharmacology. 70(3). 335–341. 112 indexed citations

14.

Duerden, Martin. (2010). Improving medicines use in care homes. Prescriber. 21(3). 8–8. 1 indexed citations

15.

Duerden, Martin. (2010). Cancer Drugs Fund: A NICE mess. Prescriber. 21(22). 8–9. 1 indexed citations

16.

Duerden, Martin, et al.. (2008). A budget impact model for a drug in heart failure: eplerenone. British Journal of Cardiology. 15(2). 101–105. 1 indexed citations

17.

Duerden, Martin. (2006). NICE appraisal of statins: the devil lies in the lack of detail?. Prescriber. 17(6). 9–10. 1 indexed citations

18.

Duerden, Martin, et al.. (2004). Current National Initiatives and Policies to Control Drug Costs in Europe. Journal of Ambulatory Care Management. 27(2). 132–138. 11 indexed citations

19.

Price, David, et al.. (2002). The Cost Effectiveness of Chlorofluorocarbon-Free Beclomethasone Dipropionate in the Treatment of Chronic Asthma. PharmacoEconomics. 20(10). 653–664. 14 indexed citations

20.

Duerden, Martin & Tom Walley. (1999). Prescribing at the Interface Between Primary and Secondary Care in the UK. PharmacoEconomics. 15(5). 435–443. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact